Full-Time

Architect Product Safety & Regulatory Engineering

GE Healthcare

GE Healthcare

1-10 employees

Imaging, monitoring, and healthcare IT solutions

No salary listed

Bengaluru, Karnataka, India

In Person

Relocation assistance is provided.

Bachelor's, Master's

Category
Biology & Biotech (1)
Required Skills
ETL
Risk Management

Get referred to GE Healthcare

See people who can refer or advise you

Requirements
  • A Bachelor's or Master's degree in Electrical Engineering, Electronics Engineering, Mechanical Engineering, or a related engineering discipline is required.
  • At least 10 years of experience in Product Safety, Regulatory Engineering, Design Controls, Quality Engineering, Medical Device Compliance, or a related technical discipline is required.
  • Knowledge of medical device regulations and standards, including IEC 60601, ISO 14971, ISO 13485, FDA regulations, EU MDR, NMPA, CDSCO, and other applicable global regulatory requirements is required.
  • Experience with Design Controls, design change management, risk management, verification and validation, product lifecycle management, and regulatory compliance is required.
  • Working knowledge of electromagnetic interference and electromagnetic compatibility requirements and product certification processes is required.
  • Experience supporting complex medical devices, preferably X-Ray Tubes, X-Ray Generators, medical imaging systems, or related electromechanical products is required.
Responsibilities
  • Provide technical leadership for Product Safety, Regulatory Compliance, Risk Management, and Design Controls for X-Ray Tubes and X-Ray Generators across new product development and lifecycle engineering activities.
  • Evaluate the impact of engineering, supplier, component, and manufacturing changes to ensure continued compliance with global regulatory and product safety requirements.
  • Lead product risk management activities, including Hazard Analysis, Risk Assessments, Design Failure Mode and Effects Analysis, Process Failure Mode and Effects Analysis, and Product Safety Reviews.
  • Lead regulatory compliance and product certification activities, including support for IEC 60601, ISO 14971, ISO 13485, FDA, EU MDR, NMPA, CDSCO, UL, CSA, ETL, RoHS, REACH, and other applicable regional requirements.
  • Drive Product Standards Review Board activities, Country Compliance Notifications, and regulatory assessments to address evolving global regulatory requirements.
  • Review and approve technical documentation including Technical Files, Design History Files, Device Master Records, Risk Management Files, product specifications, labeling, user documentation, and compliance records.
  • Provide regulatory and product safety oversight throughout the Design Control process, including Design Inputs, Design Outputs, Verification, Validation, Design Transfer, Engineering Change Requests, and Engineering Change Orders.
  • Collaborate with Engineering, Quality, Regulatory Affairs, Manufacturing, Service, Supplier Quality, and Sourcing teams to implement compliant product improvements and resolve technical compliance issues.
  • Support internal, external, regulatory, certification, and customer audits by providing technical expertise related to product safety, electromagnetic interference and electromagnetic compatibility compliance, regulatory requirements, and quality management systems.
  • Drive continuous improvement initiatives that strengthen regulatory compliance, product safety, and lifecycle engineering processes across the X-Ray Generation product portfolio.
Desired Qualifications
  • Strong technical leadership with a systems engineering mindset.
  • Demonstrated ability to influence and collaborate across global cross-functional teams.
  • Strong analytical, problem-solving, and risk-based decision-making skills.
  • Strong written and verbal communication skills with the ability to communicate complex technical concepts to diverse stakeholders.
  • Experience balancing innovation, quality, regulatory compliance, and business objectives.
  • A self-motivated approach with a continuous improvement mindset and strong execution focus.

GE Healthcare Systems provides medical technologies and digital infrastructure to improve diagnosis, treatment, and monitoring of patients. Its products include imaging systems, mobile diagnostic devices, patient monitoring tools, and healthcare IT software that work together as hardware, software, and services to support hospitals, clinics, and researchers. The company differentiates itself with a large, integrated ecosystem, strong focus on AI analytics, and a global service network backed by substantial R&D investment. Its goal is to improve patient outcomes and the efficiency of healthcare delivery by enabling accurate diagnoses, effective treatments, and scaled operations.

Company Size

1-10

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

1892

Get referred to GE Healthcare

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Photonova Spectra won CE Mark on August 31, 2026, opening Europe sales.
  • Q2 2026 orders rose 11.1%, with 1.15x book-to-bill and record backlog.
  • Vivid cardiovascular ultrasound and ABUS breast screening launches broaden 2026 revenue opportunities.

What critics are saying

  • Patient Care Solutions revenue fell 13.5% in Q2 2026; management is reviewing a sale.
  • Jay Saccaro left in August 2026; William Grogan starts September 14, 2026.
  • If PCS recovery slips into 2027, GE HealthCare becomes a slower-growth imaging vendor.

What makes GE Healthcare unique

  • Photonova Spectra’s Deep Silicon CT differentiates GE HealthCare with photon-counting imaging.
  • GE HealthCare spans imaging, pharma diagnostics, ultrasound, and monitoring across hospital workflows.
  • The July 2026 backlog of $23.9 billion reflects sticky installed-base demand and services.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Relocation Assistance

Company News

Yahoo Finance
Sep 1st, 2026
GE HealthCare secures CE mark for Photonova Spectra photon-counting CT system

GE HealthCare has received CE mark approval for its Photonova Spectra photon-counting computed tomography system, enabling commercial sales in markets recognising CE marking. The clearance follows US Food and Drug Administration approval and Japanese regulatory clearance in March 2026. The system uses GE HealthCare's Deep Silicon detector technology to deliver ultra-high definition spectral and spatial imaging. It processes data volumes up to 50 times greater than conventional CT systems, utilising Nvidia's accelerated computing platform. Clinical collaborations are underway at UZ Brussel in Belgium and Rigshospitalet in Denmark to evaluate the system across cardiology, neurology, oncology and musculoskeletal imaging. The CE mark follows more than $5 billion in innovation investment by GE HealthCare.

Yahoo Finance
Aug 31st, 2026
Vertex Pharmaceuticals shows promise while GE HealthCare and Wells Fargo face challenges

Vertex Pharmaceuticals has emerged as a standout S&P 500 stock, according to StockStory's analysis. The company, which focuses on developing transformative medicines for serious diseases including cystic fibrosis and sickle cell disease, boasts a market capitalisation of $137.3 billion. Meanwhile, StockStory recommends avoiding two large-cap stocks. GE HealthCare, spun off from General Electric in 2023, faces concerns over stagnant organic revenue growth and declining operating margins. The medical equipment provider has a market cap of $32.4 billion. Wells Fargo also made the avoid list. The diversified financial services company, with a $262.2 billion market cap, has seen its net interest margin shrink by 33.6 basis points over two years, suggesting increased competition or declining loan profitability.

Associated Press
Aug 28th, 2026
GE HealthCare launches three new Vivid cardiovascular ultrasound systems for diverse care settings

GE HealthCare has introduced three new cardiovascular ultrasound systems to its Vivid portfolio: Vivid Explorer 1, Vivid Advanced 1, and Vivid Focus 1. The systems were unveiled at the European Society of Cardiology Congress 2026 in Munich, Germany. Each system targets different clinical settings whilst sharing a common technology foundation with the ultra-premium Vivid Pioneer. Vivid Explorer is designed for high-volume echo labs, Vivid Advanced for mid-size hospitals and cardiology practices, and Vivid Focus for everyday cardiac imaging. All three systems use cSound imaging technology and include AI-enabled automation tools to streamline echo workflows. The systems have received CE Mark approval but are awaiting US FDA 510(k) clearance and are not yet available for sale in the United States.

Yahoo Finance
Aug 3rd, 2026
GE HealthCare launches Invenia ABUS Prime and StreamVue for breast cancer screening

GE HealthCare has launched Invenia ABUS Prime and ABUS StreamVue, expanding its breast imaging portfolio with solutions for supplemental screening in women with dense breasts. The Invenia ABUS Prime system has been installed at BeSound in Los Angeles, marking one of the first US installations. ABUS StreamVue is a browser-based reading solution enabling remote exam review across imaging networks. The system received FDA 510(k) clearance and CE Marking. Studies show 40% of women have dense breasts, carrying four to six times higher breast cancer risk. Research indicates mammography may miss one-third of cancers in dense breasts. Invenia ABUS Prime features AI-enabled tools including Scan Quality Assessment and can increase scan speed by up to 40%. The AI Assistant has demonstrated a 33% reduction in reading time.

Yahoo Finance
Jul 29th, 2026
GE HealthCare Q2: Orders up 11%, backlog hits record $23.9B amid Patient Care struggles

GE HealthCare Technologies reported second-quarter results with orders rising 11% year-over-year and backlog reaching a record $23.9 billion. Revenue grew 3.5% organically to $5.3 billion, driven by Advanced Imaging Solutions and Pharmaceutical Diagnostics, which posted organic growth of 5% and 14.6% respectively. Patient Care Solutions remained weak, with revenue falling 13.5% due to component shortages and fulfilment problems. Management is reviewing strategic options for the segment, including a potential sale. The company maintained its full-year outlook of 3–4% organic sales growth, adjusted earnings per share of $4.80–$5.00, and approximately $1.6 billion in free cash flow. CFO Jay Saccaro is departing, with George Newcomb serving as interim CFO.